Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders

Background: The treatment of Helicobacter pylori (HP) infection in patients with diabetes mellitus with chronic gastroduodenal disorders is a substantial problem because of its high incidence. Aims: To compare between the effectiveness of triple and optimised consecutive regimens in anti-HP treatmen...

Full description

Bibliographic Details
Main Authors: Yuri L. Fedorchenko, Marina V. Martynuk
Format: Article
Language:English
Published: Endocrinology Research Centre 2017-12-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/8689
_version_ 1797255186733858816
author Yuri L. Fedorchenko
Marina V. Martynuk
author_facet Yuri L. Fedorchenko
Marina V. Martynuk
author_sort Yuri L. Fedorchenko
collection DOAJ
description Background: The treatment of Helicobacter pylori (HP) infection in patients with diabetes mellitus with chronic gastroduodenal disorders is a substantial problem because of its high incidence. Aims: To compare between the effectiveness of triple and optimised consecutive regimens in anti-HP treatment in patients with type 2 diabetes mellitus with gastroduodenal disorders. Materials and methods: The study included 54 patients with diabetes mellitus and 64 healthy individuals (the control group) aged 30–60 years. Gastroduodenal pathology was confirmed by gastroduodenoscopy; HР contamination was confirming using Marshall’s urease method or by finding bacterial antigen in excrements. We studied the dynamics of clinical manifestations using the GSRS scale and showed remission via endoscopy and the effectiveness of HР eradication. We also analysed the effects of anti-HР therapy regimens on the presence of small intestinal bacterial overgrowth syndrome (SIBOS) in patients with diabetes mellitus. SIBOS was diagnosed via the respiratory hydrogen method. Results: The use of an optimised consecutive regimen resulted in HР eradication in 85.7% of patients with diabetes mellitus compared with a 65.3% eradication in patients on the triple therapy. Moreover, clinical improvement and endoscopy-confirmed remission were more frequently observed in patients on the optimised consecutive regimen. A statistically significant decrease in the number of patients with SIBOS was found only in patients who underwent the optimised consecutive therapy regimen. Conclusions: This study showed that the optimised consecutive therapy regimen was more effective than the triple therapy in HP eradication.
first_indexed 2024-03-08T15:19:51Z
format Article
id doaj.art-07b73f764aa1449e81dddb0d3578d44f
institution Directory Open Access Journal
issn 2072-0351
2072-0378
language English
last_indexed 2024-04-24T22:01:51Z
publishDate 2017-12-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj.art-07b73f764aa1449e81dddb0d3578d44f2024-03-20T11:48:01ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782017-12-0120642743310.14341/DM86898375Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disordersYuri L. Fedorchenko0Marina V. Martynuk1<p>Far-Eastern state medical university</p><p>City out-patient clinic №16</p>Background: The treatment of Helicobacter pylori (HP) infection in patients with diabetes mellitus with chronic gastroduodenal disorders is a substantial problem because of its high incidence. Aims: To compare between the effectiveness of triple and optimised consecutive regimens in anti-HP treatment in patients with type 2 diabetes mellitus with gastroduodenal disorders. Materials and methods: The study included 54 patients with diabetes mellitus and 64 healthy individuals (the control group) aged 30&ndash;60 years. Gastroduodenal pathology was confirmed by gastroduodenoscopy; HР contamination was confirming using Marshall&rsquo;s urease method or by finding bacterial antigen in excrements. We studied the dynamics of clinical manifestations using the GSRS scale and showed remission via endoscopy and the effectiveness of HР eradication. We also analysed the effects of anti-HР therapy regimens on the presence of small intestinal bacterial overgrowth syndrome (SIBOS) in patients with diabetes mellitus. SIBOS was diagnosed via the respiratory hydrogen method. Results: The use of an optimised consecutive regimen resulted in HР eradication in 85.7% of patients with diabetes mellitus compared with a 65.3% eradication in patients on the triple therapy. Moreover, clinical improvement and endoscopy-confirmed remission were more frequently observed in patients on the optimised consecutive regimen. A statistically significant decrease in the number of patients with SIBOS was found only in patients who underwent the optimised consecutive therapy regimen. Conclusions: This study showed that the optimised consecutive therapy regimen was more effective than the triple therapy in HP eradication.https://www.dia-endojournals.ru/jour/article/view/8689helicobacterpylorydiabetes mellitusgastroduodenal diseases
spellingShingle Yuri L. Fedorchenko
Marina V. Martynuk
Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
Сахарный диабет
helicobacterpylory
diabetes mellitus
gastroduodenal diseases
title Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
title_full Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
title_fullStr Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
title_full_unstemmed Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
title_short Treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
title_sort treatment of helicobacter pylori contamination in patients with type 2 diabetes mellitus with gastroduodenal disorders
topic helicobacterpylory
diabetes mellitus
gastroduodenal diseases
url https://www.dia-endojournals.ru/jour/article/view/8689
work_keys_str_mv AT yurilfedorchenko treatmentofhelicobacterpyloricontaminationinpatientswithtype2diabetesmellituswithgastroduodenaldisorders
AT marinavmartynuk treatmentofhelicobacterpyloricontaminationinpatientswithtype2diabetesmellituswithgastroduodenaldisorders